Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126943461 | 12694346 | 1 | I | 2016 | 20160820 | 20160829 | 20160829 | PER | US-AMGEN-USASL2016111359 | AMGEN | 55.00 | YR | A | F | Y | 0.00000 | 20160829 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126943461 | 12694346 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | 103795 | UNKNOWN FORMULATION | |||||||||
| 126943461 | 12694346 | 2 | SS | NYSTATIN. | NYSTATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126943461 | 12694346 | 3 | SS | NYSTATIN. | NYSTATIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126943461 | 12694346 | 1 | Product used for unknown indication |
| 126943461 | 12694346 | 2 | Unevaluable event |
| 126943461 | 12694346 | 3 | Sinusitis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126943461 | 12694346 | Dizziness | |
| 126943461 | 12694346 | Sinusitis | |
| 126943461 | 12694346 | Unevaluable event |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126943461 | 12694346 | 1 | 20160813 | 0 |